Näytetään tekstit, joissa on tunniste Children’s Health Defense. Näytä kaikki tekstit
Näytetään tekstit, joissa on tunniste Children’s Health Defense. Näytä kaikki tekstit

maanantai 26. tammikuuta 2026

Children’s Health Defense Hits AAP With RICO Suit Over Fraudulent Vaccine Safety Claims

.


  • In a lawsuit filed today (January 21, 2026) in federal court, Children’s Health Defense (CHD) and five other plaintiffs accused the American Academy of Pediatrics (AAP) of running a decades-long racketeering scheme to defraud American families about the safety of the childhood vaccine schedule.
  • “For too long, the AAP has been held up on a pedestal, as if it were a font of science and integrity,” said CHD CEO Mary Holland. - “Sadly, that’s not the case.”


T=1769406787 / Human Date and time (GMT): Mon, 26th Jan. 2026, 05.53

___ 

January 21, 2026  Big Pharma  Health Conditions  News

Legal

Breaking: Children’s Health Defense Hits AAP With RICO Suit Over Fraudulent Vaccine Safety Claims

Children’s Health Defense (CHD) and five other plaintiffs today accused the American Academy of Pediatrics of running a decades-long racketeering scheme to defraud American families about the safety of the childhood vaccine schedule. CHD filed the RICO suit in the U.S. District Court for the District of Columbia

aap logo and gavel


In a lawsuit filed today in federal court, Children’s Health Defense (CHD) and five other plaintiffs accused the American Academy of Pediatrics (AAP) of running a decades-long racketeering scheme to defraud American families about the safety of the childhood vaccine schedule.

The suit alleges that the AAP violated the Racketeer Influenced and Corrupt Organizations Act (RICO) by making “false and fraudulent” claims about the safety of the Centers for Disease Control and Prevention’s (CDC) childhood immunization schedule — while receiving funding from vaccine manufacturers and providing financial incentives to pediatricians who achieve high vaccination rates.

“For too long, the AAP has been held up on a pedestal, as if it were a font of science and integrity,” said CHD CEO Mary Holland. “Sadly, that’s not the case.”

Instead, Holland said, the AAP “is a front operation in a racketeering scheme involving Big Pharma, Big Medicine and Big Media, ready at every turn to put profits above children’s health. It’s time to face facts and see what the AAP is really about,” Holland said.

According to the complaint, the AAP has worked to conceal the findings of studies that the Institute of Medicine (IOM) — now known as the National Academy of Medicine — published in 2002 and 2013.

The IOM called for more research after concluding that no studies had ever been conducted to compare the health outcomes of vaccinated and unvaccinated children.

The AAP’s conduct constitutes a pattern of fraud under RICO, a statute often used to prosecute organized crime, said Rick Jaffe, attorney for the plaintiffs.

Jaffe told The Defender that while previous lawsuits “challenged individual vaccines or sought compensation for individual injuries,” this “is a fraud case following the playbook that took down Big Tobacco.”

“The AAP’s actions parallel those of Big Tobacco, which misled the public regarding the safety of its products,” Jaffe said. “Tobacco created false uncertainty to manufacture doubt. The AAP did the inverse — it created false certainty to foreclose questions. Both used the trappings of science to prevent actual science.”

CHD General Counsel Kim Mack Rosenberg said the lawsuit shows “the close ties between entities and individuals who work toward the same purpose — propping up the vaccine industry and those who profit from it.”

The AAP is the largest pediatric trade group in the U.S., with 67,000 members.

The lawsuit, filed in the U.S. District Court for the District of Columbia, seeks financial damages for the individual plaintiffs. It also asks the court to require the AAP to disclose the “lack of comprehensive safety testing” of vaccines, and bar the AAP from making “further unqualified safety claims” about vaccines.

Drs. Paul Thomas and Kenneth Stoller — physicians whose professional reputations were harmed for opposing AAP’s guidelines, and the parents of four children who died or were injured after receiving routine childhood vaccinations, are among the plaintiffs.

Lawsuit: AAP’s childhood vaccine safety claims based on ‘foundational fraud’

According to the lawsuit, the AAP’s claims about vaccine safety rest on a “foundational fraud” — namely, a 2002 article by pediatrician Dr. Paul Offit, published in the journal Pediatrics. The article claims that infants can “theoretically” receive up to 10,000 vaccines at once without posing a health risk.

The AAP “deployed this theoretical reassurance” to block the IOM studies and questions about the safety of the childhood schedule, to assure parents, doctors and policymakers that the vaccine schedule was thoroughly tested, the complaint states.

The AAP incorporated Offit’s claims into its flagship Red Book — its guide to the prevention, management and control of pediatric diseases. “Pediatricians learned to cite the 10,000 vaccines figure when parents expressed concern,” the complaint states.

“The Red Book is their Bible. When AAP says the schedule is safe, that’s what parents hear in examination rooms across America,” Jaffe said.

“Offit’s theoretical PR article did not study, and could not prove, the safety of the cumulative schedule,” according to the complaint. Yet the pediatricians who deviate from this standard of care have faced professional and personal consequences.

‘AAP turned pediatricians into vaccine delivery systems’

Thomas and Stoller, the two pediatricians who are suing the AAP, said they suffered professional and economic harm after questioning vaccine safety claims.

In 2020, Thomas co-authored research, now retracted, comparing the health outcomes of vaccinated and unvaccinated children. Days later, the Oregon Medical Board suspended Thomas, citing his deviation from AAP protocols and calling him a “threat to public health.”

“I was forced to abandon my patients, something highly illegal,” Thomas said. “There was economic damage in the millions and devastating stress and emotional duress.”

Stoller also faced professional discipline and reputational harm, according to the complaint. He lost his medical license in California and New Mexico after he granted medical exemptions to vaccine mandates.

“AAP turned pediatricians into vaccine delivery systems and destroyed the ones who asked questions,” Jaffe said.

AAP guidelines led to children’s vaccine-related deaths and injuries

The AAP’s “Red Book” vaccine recommendations contributed to the deaths and injuries of three of the plaintiffs’ children, according to the lawsuit.

Idaho resident Andrea Shaw’s two children — fraternal twins Dallas and Tyson Shaw — both died last year, eight days after receiving their 18-month vaccines.

According to the complaint, the Shaw family’s physician dismissed the parents’ warnings about the family’s history of adverse reactions to the flu vaccine. The doctor was following AAP guidance, “which does not generally recognize family history of vaccine reactions.”

A day after their vaccination, Shaw’s children were taken to the emergency room for a series of symptoms documented as “post-immunization reaction, initial encounter.”

A week later, the children died. Local authorities launched a homicide investigation against their mother, based on the suspicion that she caused their deaths. The investigation is still active.

New York resident Shanticia Nelson’s 1-year-old daughter, Sa’Niya Carter, died last year of cardiac arrest after having seizures roughly 12 hours after receiving six “catch-up” injections containing 12 vaccines.

Nelson told doctors she was concerned about giving her daughter so many vaccines at once, because the child was sick at the time. However, healthcare workers told Nelson that the “catch-up” regimen and vaccinating a “mildly ill” child were safe, according to the AAP.

Carter’s death certificate listed “sudden unexpected death in childhood” as the official cause of death. However, the coroner found signs of encephalitis, a condition linked to the DTaP (diphtheria, tetanus and pertussis) vaccine, which Carter had received.

“Shaw and Nelson’s stories show what happens when AAP’s paradigm corrupts medical judgment at the point of care,” the complaint states.

Plaintiff Jane Doe’s daughter, “E,” a high school student in New York, sustained anaphylactic reactions after getting three routine childhood vaccines.

The student later obtained a medical exemption from all further vaccinations. But in 2024, her school’s medical consultant revoked the exemption — and two more exemptions “E” had obtained — citing AAP guidelines.

After school officials said she couldn’t return to school unless she complied with state vaccine mandates, “E” became suicidal — so her parents allowed her to “catch up” on her vaccines.

After getting those shots, “E” had a severe allergic reaction and was diagnosed with arthropathy, a joint disease, requiring surgery and ongoing care. Arthropathy has been linked to the measles-mumps-rubella (MMR) vaccine, which “E” had received.

“Jane Doe’s story shows what happens when treating physicians get it right and the AAP paradigm overrides them,” the complaint states.

Complaint highlights AAP’s conflict of interest with vaccine makers

The AAP maintains financial relationships with vaccine manufacturers, including Pfizer, Merck, GlaxoSmithKline (GSK) and Sanofi Pasteur, and also with the federal government. However, the group doesn’t disclose these relationships in its policy statements and public safety assurances, according to the complaint.

This has led to conflicts of interest, including the formation of an “association-in-fact enterprise,” referring to “individuals or entities that operate together for a common purpose without forming a formal legal entity.”

“The same pharmaceutical conglomerates that serve as enterprise participants in manufacturing childhood vaccines have systematically acquired companies treating the chronic conditions those vaccines cause, creating a closed-loop system that financializes childhood illness,” the complaint states.

The complaint alleges that AAP has subsequently resisted any changes to the childhood vaccination schedule, including those enacted under the leadership of U.S. Health Secretary Robert F. Kennedy Jr.

Last year, the AAP and other medical organizations sued Kennedy and other federal health officials and agencies. The groups seek to roll back the changes the U.S. Department of Health and Human Services (HHS) made to the childhood schedule. Last week, the AAP updated its complaint after HHS reduced the number of recommended childhood vaccines from 17 to 11 earlier this month.

The AAP last year released its own “evidence-based” immunization schedule, identical to the CDC’s childhood immunization schedule as it was before Kennedy became health secretary. Several states have adopted the AAP’s schedule.

AAP later rejected the CDC Advisory Committee on Immunization Practices (ACIP) vote to end hepatitis B shots for newborns, claiming children will “die” as a result. HHS removed AAP members from ACIP work groups last year. AAP’s updated lawsuit also asks the court to block ACIP’s next meeting in February.

In a separate lawsuit filed last month, the AAP demanded HHS restore $12 million in research grants that HHS withdrew last year. Last week, a federal judge reinstated the funding. AAP has also called for the prohibition of religious and philosophical exemptions to vaccination.

When HHS “has attempted reform, AAP leads the opposition,” the complaint states.

Mack Rosenberg said the AAP “fails to follow the actual science” in its lawsuits. Instead, the organization relies “only on that which supports its position that the childhood schedule is ‘safe and effective.’”

Plaintiffs compare AAP’s actions to those of Big Tobacco 

The complaint draws parallels between AAP’s actions and tobacco companies’ efforts to conceal the dangers of smoking, which the U.S. Department of Justice prosecuted in a landmark RICO case, U.S. v. Philip Morris USA.

In the Philip Morris case, a federal court found that the tobacco industry was liable for denials about the health risks of tobacco spanning several decades.

The complaint states there are parallels between the AAP’s actions and those of Big Tobacco, including “suppression of adverse research, use of ‘independent’ scientific voices to block studies, and coordinated enterprise activity to mislead the public.”

This is the latest in a series of lawsuits CHD has filed. These include lawsuits against:

Please make a donation today to support CHD’s work to protect children.

Related articles in The Defender

keskiviikko 5. marraskuuta 2025

Historical Development of the Mercury Based Preservative Thimerosal

HHS Adopts ACIP Recommendation to Remove Thimerosal from All U.S. Influenza Vaccines
WASHINGTON, DC—JULY 23, 2025U.S. Health and Human Services Secretary Robert F. Kennedy, Jr. took action.

The CDC’s Advisory Committee on Immunization Practices met in June to review and vote on several vaccine recommendations. Shortly before the meeting, however, Kennedy added additional items to the agenda, including a discussion of thimerosal—a preservative that is used in some vaccines. Committee members voted to recommend the reversal of the long-standing recommendation for flu vaccine formulations containing thimerosal. - June 25, 2025


___

Date: 5.11.2025,  Time: 4.11 (GMT +2)

Thimerosal History


Historical Development of the Mercury Based Preservative Thimerosal


Before the invention of modern antibiotics and antiseptics, physicians experimented with “germicides,” including acids and mercury-containing compounds, to try to stave off microbial pathogens. Thimerosal was born of these efforts in the early 20th century. Thimerosal is an organic compound made up of equal parts of thiosalicylic acid and ethylmercury. It is 49.6 percent ethylmercury by weight. Thimerosal was developed by Dr. Morris Kharasch, a chemist and Eli Lilly fellow first at the University of Maryland (1922-1927) and then at the University of Chicago. He filed for a patent on June 27, 1929, for what he described as an alkyl mercuric sulfur compound (thimerosal), which he felt had potential as an antiseptic and antibacterial product.

In October 1929, Eli Lilly and Company registered thimerosal under the trade name Merthiolate. Merthiolate was used to kill bacteria and prevent contamination in antiseptic ointments, cremes, jellies, and sprays used by consumers and in hospitals. Thimerosal was also used in nasal sprays, eye drops, contact lens solutions, immunoglobulins, and most importantly here – vaccines. Thimerosal was patented the same year that Alexander Fleming discovered penicillin. To the medical profession, who were without antibiotics during the 1930s and 1940s, thimerosal (marketed as Merthiolate) and other antiseptic products were welcome additions to combating life threatening bacterial infections.

Eli Lilly investigators H. M. Powell and W. A. Jamieson reported in 1931 that various animals seemed to tolerate high doses of thimerosal.
Rabbits, for example, tolerated on the order of 25 milligrams per kilogram of body weight—comparatively much higher than those ever used in vaccines. However, many of those animals given higher doses did die of evident mercury poisoning just days later. Also notable in these early animal toxicity studies and many later research efforts:
The researchers failed to assess or perform socialization behaviors and cognition tests. In other words, though the animals may have survived thimerosal exposure, their social behavior might have been altered as a result of mercury-induced brain damage. During this time period, Powell and Jamieson also reported on the first injection of thimerosal into humans.

In 1929, during an epidemic of meningococcal meningitis in Indianapolis, K. C. Smithburn administered thimerosal to twenty-two (22) ill patients at Indianapolis City Hospital. The thimerosal had no apparent therapeutic benefit, and all the patients died, seven (7) of them within one (1) day of thimerosal administration.

Despite the deaths of all of these patients, Powell and Jamieson described the experiment as a success. 

[The FDA standard for drug safety is known as LD 50, LD stands for lethal dose, and the 50 is the percentage threshold of lab animals poisoned to death by the drug tested. As long as the percentage killed is under 50%, FDA will approve it!]


The drug was administered intravenously and the authors reported that their patients seemed to tolerate the high dosages of the 1 percent thimerosal solution. The scientists involved in thimerosal research at the time published a paper that made a brief reference to this study: “Merthiolate was injected intravenously into 22 persons… these large doses did not produce any anaphylactoid or shock symptoms.” But neither of these side effects is associated with toxic mercury exposure, which can take months before presenting symptoms. This study was not designed to examine toxicity; only 7 of 22 subjects were observed for only one day, the specific clinical assessments were not described, and no laboratory studies were reported.
Apparently, because of the abbreviated survival period, the longest that Powell and Jamieson were able to observe a patient was only sixty-two (62) days after the administration of thimerosal. Importantly, the Powell and Jamieson study neglected to mention that the patients given thimerosal by Smithburn were not healthy individuals. It is possible, therefore, that any short-term neurological or other deleterious effects of the thimerosal would have been masked by or attributed to the patients’ meningitis infections.

In the paper, the authors acknowledge that Dr. K.C. Smithburn, the clinician who treated the meningitis patients, was not convinced of its efficacy: “beneficial effects of the drug were not definitely proven.” Drs. Powell and Jamieson also noted in 1930 that a “wide range of toxicity and injury tests should be done.” There is no evidence that Drs. Powell and Jamieson took their own advice and conducted studies to address these concerns. Eli Lilly used the Smithburn, Powell, and Jamieson results for decades as evidence of thimerosal’s safety paving the way for inclusions into various antiseptic products, including nasal sprays, eyewashes, vaginal spermicides, and diaper rash treatments. 

Starting in the 1930s, pharmaceutical companies began to use thimerosal in vaccines for the intended purpose of preventing bacterial contamination due to repeated needle punctures into multi-does vials of vaccine.


Thimerosal Timeline: Pre-1999 to 2004

In July 1999, a joint statement by the AAP and Public Health Service was released to the press advising Americans that the amount of mercury in vaccines administered to children, through a preservative called Thimerosal, exceeded Federal Health guidelines. But this wasn’t a revelation. The following “Thimerosal Timeline: Pre-1999 to 2004” created by Put Children First documents when who knew what.

View/Download PDF

Developmental neurotoxicants and the vulnerable male brain: a systematic review of suspected neurotoxicants that disproportionally affect males

The prevalence of neurodevelopmental disorders (NDs), including autism spectrum disorder, attention‑deficit/hyperactivity disorder, tic disorder, obsessive‑compulsive disorder, and emotional disturbances, has increased notably in the past few decades. To date, debate continues as to the origins of NDs. Increases in widespread exposure to and bioaccumulation of chemical neurotoxicants have paralleled the upsurge in NDs, and are suggested to be causal agents for NDs. One consistent aspect of NDs is the male preponderance.

View/Download PDF

Review of Thimerosal in Over-the-counter products by the Center for Drug Evaluation and Research (1974-1998)

In 1974, the FDA undertook a comprehensive review of the safety and effectiveness of over-the-counter medicines. As one facet of this review, a panel of experts was assembled to review the safety and efficacy of over-the-counter drugs containing mercury. The Advisory Review Panel on OTC Miscellaneous External Drug Products began this review in 1975. In 1980, the panel delivered its report to the FDA. It reviewed 18 products containing mercury, and found them all either unsafe or ineffective for their stated purpose of killing bacteria to prevent infections.

View/Download PDF

OSC Forwards Public Health Concerns on Vaccines to Congress

The Office of Special Counsel (OSC) today forwarded to Congress hundreds of disclosures alleging public health and safety concerns about childhood vaccines that include a mercury-based preservative known as thimerosal, and its possible link to neurological disorders, including autism. Notwithstanding a new Institute of Medicine study released yesterday that concludes there is no link between thimerosal and autism, the OSC sent copies of the letters to both Senator Judd Gregg and Rep. Joe Barton, to ensure that the proper Congressional oversight committees are aware of these serious allegations.

View/Download PDF

Eli Lilly: The History and Politics Involving Thimerosal Containing Vaccines and Neurological Development Disorders Including Autism

In early 2000, a law firm who had filed a court case claiming that thimerosal was not a necessary vaccine ingredient in civil court was able to bypass the National Vaccine Injury Compensation Program (NVICP). During the discovery process the firm received internal documents from Eli Lilly who first patented Thimerosal in 1929. The information below is what the law firm presented to the judge in the case. This document descries the long and sordid history of thimerosal and confirms that this potent neurotoxin can cause neurodevelopmental injury and should never been used in vaccines. As a result of this case, a rider was added to the Homeland Security Bill the night before it was voted on and approved by Congress that included a provision that any company who makes an ingredient used in a vaccine is covered under the NVICP.

View/Download PDF

Review of Thimerosal by the Food and Drug Administration as Required by the Food and Drugs Administration Modernization Act (1997-1999)

Over-the-counter (OTC) products and vaccines are regulated by different branches of the FDA. OTCs are regulated by the Center for Drug Evaluation and Research (CDER). Vaccines are regulated by the Center for Biologics Evaluation and Research (CBER). The FDA’s determination that mercury was unsafe and should be removed from over-the-counter medications was published in the Federal Register no fewer than five times prior to the FDA’s belated review of mercury in vaccines. What finally prompted the FDA to review mercury in vaccines was not its own regulatory process, but rather an act of Congress.

View/Download PDF

Thimerosol is a Developmental Neurotoxicant

Dr. Lucier is the Retired Director of the Environmental Toxicology Program, National Institutes of Environmental Health Sciences.

View/Download PDF

"datePublished":"2016-11-02T06:44:09+00:00","dateModified":"2018-09-07T04:06:43+00:00"

SOURCE
https://childrenshealthdefense.org/known-culprits/mercury/thimerosal-history/

___


https://childrenshealthdefense.org/chd-2025-conference/?itm_term=homehero

___



https://childrenshealthdefense.org/

___
eof